Key result
Exosomes emerge as promising diagnostic biomarkers for cardiovascular disease and sudden cardiac death.
Why the study?
Forensic identification of sudden cardiac death relies on traditional histomorphological examination and lacks stable biomarkers with high specificity and sensitivity.
Exosomes represent a promising novel biomarker platform for both the clinical diagnosis of cardiovascular diseases and the forensic identification of sudden cardiac death.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for exosome biomarkers in cardiovascular disease and sudden cardiac death; prospective validation required before clinical or forensic adoption.
Sudden cardiac death (SCD) is a common cause of death due to the high prevalence and mortality of cardiovascular disease (CVD). Currently, the forensic identification of SCD relies on traditional histomorphological examination, lacking stable biomarkers with high specificity and sensitivity. Previous studies have shown that exosomes (Exos) are ideal vectors and the application of Exos provides novel insight as the diagnostic biomarkers and treatment of CVD, and is hot research filed in biomedicine. This review briefly describes the biology of Exos, including the biogenesis of Exos and the mechanisms of action. The research progresses on Exos multi-omics, i.e., genomics, proteomics and metabolomics, and their roles in the diagnosis of different types of CVD, especially coronary heart disease and cardiomyopathy, are summarized. In addition, the current difficulties of applications of Exos in forensic identification of SCD and the prospective forensic applications in the future are highlighted. The aim of this review is to summarize the current advances of Exos in CVD in a disease-oriented manner, and to provide a reference for future forensic pathological identification of SCD, as well as the early diagnosis of SCD in clinic.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) conducted a review in Cardiovascular disease and sudden cardiac death. Exosomes was evaluated. Exosomes provide novel insights as diagnostic biomarkers for cardiovascular diseases and hold prospective value for the forensic identification and early clinical diagnosis of sudden cardiac death.
Synapse has enriched 10 related papers. Consider them for comparative context: